Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. Added

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description discloses substantial behavior beyond annotations: fan-out across many sources, per-section return semantics, USPTO soft-fail behavior, expected-empty FDA sections, resolved:false for private companies, and the sources_used/sources_failed audit fields. It reinforces the readOnly/openWorld/idempotent annotations without contradicting them.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but front-loaded with trigger phrases and a clear preference directive. Each section of the return object is described with expected behavior. Some material repeats schema information, so it could be tightened slightly, but overall it is well-structured for a complex tool with no output schema.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, so the description carries the full burden of explaining return values. It enumerates all major output sections—cik, filings, fundamentals, patents, federal_contracts, fda_products, hiring, news, LEI, and sources_used/sources_failed—and explains edge cases like private companies and expected-empty sections. Nothing critical is missing.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% and already documents type and value with examples. The description adds value by stating that type accepts 'company' or 'ticker' interchangeably and by explaining how a private-company name resolves to resolved:false rather than a bare failure. Much is redundant with the schema, so this is strong but not a 5.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description uses specific verbs and a clear resource: it profiles US public companies with 'full cross-source profile... in ONE parallel call.' It also distinguishes itself from chained single-pack lookups, helping an agent separate it from siblings like resolve_entity or compare_entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says 'ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view.' It also states what happens for private companies, notes that person/place queries are not yet supported, and clarifies that empty result sections are expected data absence, not failures.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation3/5

Several tools occupy adjacent territory: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all answer questions with only subtle differences in grounding and breadth, and discover_tools overlaps with suggest_questions. The prediction-market tools (polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, polymarket_fill_risk, polymarket_kalshi_spread, bet_research) each have distinct mechanics but a less careful agent could easily misfire between them.

Naming Consistency3/5

Most tools follow a verb_noun pattern (ask_pipeworx, compare_entities, generate_llms_txt, list_subscriptions), but there are notable exceptions: performance_review_generate reverses the order, entity_profile is noun_noun, and recall/remember/forget are bare verbs. The pipeworx_ and polymarket_ prefixes help group families, but the mixed styles prevent a higher score.

Tool Count2/5

At 32 tools this is a heavy surface for one MCP server, exceeding the 25+ threshold where agents struggle to discover and choose among options. The breadth is understandable given the many subdomains (data lookups, prediction markets, memory, subscriptions, feedback), but the count still feels like tool sprawl rather than a tightly scoped set.

Completeness4/5

As a data/research/prediction-market platform the surface is remarkably complete: query, grounded verification, deep research, entity resolution, comparisons, claim validation, visibility audits, subscriptions, memory, and feedback loops are all covered. Minor gaps exist—there is no direct tool for bulk exports or for editing subscriptions, and some meta-tools duplicate discovery—but agents can accomplish the core workflows without dead ends.